ANI PHARMACEUTICALS, INC Increase (Decrease) in Restricted Cash
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Restricted Cash of $5.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-03-02
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $1.00K.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for the quarter ending 2015-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2016 was $5.00M.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2015 was $0.00.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2014 was $0.00.
- ANI PHARMACEUTICALS, INC increase (decrease) in restricted cash for fiscal 2013 was -$2.26M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.00K derived: sum of 2 quarters · filed 2017-03-02 | $5.00M 10-K · filed 2017-03-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $5.00M 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | $5.00M 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-02 | |||
| 2013-12-31 | -$2.26M 10-K · filed 2016-02-23 | |||
| 2013-03-31 | $2.26M 10-Q · filed 2013-05-10 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |